Prevention and management of lung cancer in China. Issue 17 (1st September 2015)

• Record Type: Journal Article
• Authors: Hong, Qun‐Ying; Wu, Guo-Ming; Qian, Gui‐Sheng; Hu, Cheng‐Ping; Zhou, Jian‐Ying; Chen, Liang‐An; Li, Wei‐Min; Li, Shi‐Yue; Wang, Kai; Wang, Qi; Zhang, Xiao‐Ju; Li, Jing; Gong, Xin; Bai, Chun‐Xue; on behalf of the Lung Cancer Group of the Chinese Thoracic Society; Chinese Alliance Against Lung Cancer
• Is Part Of: Cancer. Volume 121:Issue 17(2015)
• Page Start: 3080
• Page End: 3088
• Publication Date: 2015-09-01
• Subjects: Cancer -- Periodicals; Cancer -- Cytopathology -- Periodicals; 616.99405
• DOI: 10.1002/cncr.29584
• Languages: English
• ISSNs: 0008-543X

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Lung cancer is the leading cause of cancer‐related death worldwide. In China, the incidence of lung cancer has grown rapidly, resulting in a large social and economic burden. Several researchers have devoted their studies to lung cancer and have demonstrated that there are many risk factors for lung cancer in China, including tobacco use, environmental pollution, food, genetics, and chronic obstructive pulmonary disease. However, the lung cancer incidence is still growing rapidly in China, and there is an even higher incidence among the younger generation. One explanation may be the <italic>triple‐neglect</italic> situation, in which medical policies that neglect <italic>prevention</italic>, <italic>diagnosis</italic>, and <italic>supportive care</italic> have increased patients' mortality and reduced their quality of life. Therefore, it is necessary to enhance the efficiency of prevention and early diagnosis not only by focusing more attention on treatment but also by drawing more attention to supportive care for patients with lung cancer. <bold><italic>Cancer</italic> 2015;121:3080‐8</bold>. © <italic>2015 American Cancer Society</italic>.</p> </abstract>